Suchergebnisse - "rucaparib"

PubPharm (70)

1

Personalized medicine for metastatic prostate cancer : The paradigm of PARP inhibitors

enthalten in: Critical reviews in oncology/hematology | 2023

von Maiorano, B. | Conteduca, V. | Catalano, M. | +4

2

Rucaparib for PARP inhibitor-pretreated ovarian cancer : A GEICO retrospective subgroup analysis from the Spanish Rucaparib Access Program

enthalten in: Gynecologic oncology reports | 2023

von Yubero, A. | Estévez, P. | Barquín, A. | +8

3

Safety of PARP inhibitors as maintenance therapy in ovarian cancer

enthalten in: Expert opinion on drug safety | 2023

von Cecere, S. | Casartelli, C. | Forte, M. | +2

4

Matching BRCA and prostate cancer in a public health system : Report of the Italian Society for Uro-Oncology (SIUrO) consensus project

enthalten in: Critical reviews in oncology/hematology | 2023

von Lapini, A. | Caffo, O. | Conti, G. | +9

5

Ki67 as a Predictor of Response to PARP Inhibitors in Platinum Sensitive BRCA Wild Type Ovarian Cancer : The MITO 37 Retrospective Study

enthalten in: Cancers | 2023

von Tuninetti, V. | Ghisoni, E. | Pignata, S. | +22

6

The PARP inhibitor Rucaparib synergizes with radiation to attenuate atypical teratoid rhabdoid tumor growth

enthalten in: Neuro-oncology advances | 2023

von Alimova, I. | Murdock, G. | Pierce, A. | +5

7

Ki67 as a Predictor of Response to PARP Inhibitors in Platinum Sensitive BRCA Wild Type Ovarian Cancer: The MITO 37 Retrospective Study

in: Cancers | 2023

von Valentina Tuninetti | Eleonora Ghisoni | Sandro Pignata | +22

8

Clinical Application of Poly(ADP-ribose) Polymerase (PARP) Inhibitors in Prostate Cancer

enthalten in: Cancers | 2022

von Inderjeeth, A. | Topp, M. | Sanij, E. | +2

9

Rucaparib in recurrent ovarian cancer : real-world experience from the rucaparib early access programme in Spain - A GEICO study

enthalten in: BMC cancer | 2022

von Yubero, A. | Barquín, A. | Estévez, P. | +21

10

Rucaparib in recurrent ovarian cancer: real-world experience from the rucaparib early access programme in Spain – A GEICO study

enthalten in: BMC cancer | 2022

von Yubero, A. | Barquín, A. | Estévez, P. | +21

1
2
3
4
5
6
7
Nächster »
[7]